Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-11

Clinical Trial Update: Asciminib With or Without Sildenafil for Brain Tumors [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial at Washington University is evaluating asciminib with or without sildenafil for brain tumors; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SCEMBLIX (ASCIMINIB)
  • Viagra (Sildenafil)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Brain Tumor | EARLY_Phase 1 | Status: NOT_YET_RECRUITING